Critical limb ischemia (CLI) is the most advanced form of peripheral arterial disease (PAD) that currently impacts one in every 20 Americans over the age of 50, an incidence expected to increase with a growing aging population.(2)
ISET Spotlight: Fully Percutaneous Femoropopliteal Bypass: First-of-its-Kind Procedure for Patients With Peripheral Artery Disease
Lower-extremity peripheral artery disease (PAD) is the third-leading cause of atherosclerotic cardiovascular morbidity, following coronary artery disease and stroke. PAD affects more than 200 million people worldwide, and the prevalence of PAD is increasing as baby boomers enter high-risk age groups. With estimates of more than 20% of the population projected to age into the 65-and-over cohort by the year 2050, PAD is a growing epidemic with staggering social and economic costs.
New, Longer 220 mm Length of Lutonix 035 Drug-Coated Balloon Reduces Cost at Arkansas Heart Hospital
The newest device that we have been able to use has been the 220 mm length version of the Lutonix 035 drug-coated balloon (BD/Bard). We have used this product since it launched in August and have done six cases thus far, all with great results.
We present a case that describes an additional application of the CrossLock catheter. In this case, we first access a superficial femoral artery (SFA) total occlusion via an antegrade approach using a standard sheath.
Aspiration Mechanical Thrombectomy for Acute Lower-Limb Ischemia Secondary to Thrombosed Popliteal Artery Aneurysm
This case report shows our initial experience with the Indigo vacuum-assisted thrombectomy system as an alternative therapy for the treatment of popliteal artery aneurysm.
AMP Symposium 2018 Live Case: Evidence of Today and Tomorrow: Defining Arterial Algorithms for Success
Live Case Operator: D Chris Metzger, MD
Moderator: Thomas Shimshak, MD
Panelists: Steve Henao, MD,FACS,FACC; Robert Lookstein, MD,MHCDL, FSIR, FAHA, FSVM
This non-accredited/non-approved for CECHs activity is sponsored by Boston Scientific.
Comparative Effectiveness Study of Drug-Eluting and Bare-Metal Peripheral Artery Stents in Endovascular Femoropopliteal Artery Revascularization
This study compared clinically driven target-lesion revascularization (TLR), target-vessel revascularization (TVR), and target-limb revascularization outcomes at 1 year between DES and BMS treatments in a real-world setting.
This case demonstrates the steps of sealing a flow-limiting, iatrogenic CFA dissection during primary percutaneous coronary intervention, including a novel balloon angioplasty technique.
High Prevalence of Asymptomatic Ischemia-Producing Coronary Stenosis in Patients With Critical Limb Ischemia: Anatomic and Functional Assessment With Coronary CT-Derived Fractional Flow Reserve (FFRct)
CLI patients with no cardiac history undergoing limb salvage surgery have a high prevalence of asymptomatic ischemia-producing coronary stenosis which may put them at increased risk. Pre-operative diagnosis with FFRct analysis may increase focus on peri- and post-operative cardiac care and improve outcomes.
No More Crush on the AT: SOBE Vascular Balloon Protection Technique With the MicroMedical Stent System
The Mount Sinai Medical Center featured the first in-man MicroStent and has thus far completed 5 total cases, all with procedural success and no complications in up to 30-day follow-up.